General Information of the Compound
| Compound ID |
CP0935344
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(5R*)-N5-(4-Trifluoromethoxy-phenyl-methyl)-(6R*)-N6-(4-pyrrolidin-1-yl-butyl)-(4S*,7R*)-[4,7-ethenylene-spiro[2.4]heptane]-5,6-dicarboxamide, formate saltc
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C28H36F3N3O5
|
||||||||||||||||||
| Molecular Weight |
551.606
|
||||||||||||||||||
| Canonical SMILES |
O=C(NCCCCN1CCCC1)[C@H]1[C@H](C(=O)NCc2ccc(OC(F)(F)F)cc2)[C@@H]2C=C[C@H]1C21CC1.O=CO
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H34F3N3O3.CH2O2/c28-27(29,30)36-19-7-5-18(6-8-19)17-32-25(35)23-21-10-9-20(26(21)11-12-26)22(23)24(34)31-13-1-2-14-33-15-3-4-16-33;2-1-3/h5-10,20-23H,1-4,11-17H2,(H,31,34)(H,32,35);1H,(H,2,3)/t20-,21+,22-,23-;/m1./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
IZAPXZBFBJSUPW-AMMBCFRFSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00605, FML2_HUMAN
Protein ID: PT02590, N-formyl peptide receptor 2